Di Lu

3.2k total citations · 1 hit paper
88 papers, 2.2k citations indexed

About

Di Lu is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Di Lu has authored 88 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 27 papers in Hepatology and 22 papers in Surgery. Recurrent topics in Di Lu's work include Organ Transplantation Techniques and Outcomes (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Liver Disease Diagnosis and Treatment (13 papers). Di Lu is often cited by papers focused on Organ Transplantation Techniques and Outcomes (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Liver Disease Diagnosis and Treatment (13 papers). Di Lu collaborates with scholars based in China, Madagascar and United States. Di Lu's co-authors include Xiao Xu, Jianguo Wang, Xiaonan Xiang, Shusen Zheng, Xuyong Wei, Haiyang Xie, Jianyong Zhuo, Zuyuan Lin, Qi Ling and Lin Zhou and has published in prestigious journals such as Nature Communications, Biomaterials and Hepatology.

In The Last Decade

Di Lu

80 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting tumor-associated macrophages to synergize tumor immunotherapy

2021 656 citations Xiaonan Xiang, Jianguo Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Di Lu China	22	869	572	533	478	469	88	2.2k
Masaaki Takamura Japan	28	870 1.0×	542 0.9×	356 0.7×	332 0.7×	497 1.1×	100	2.2k
Shengping Li China	24	467 0.5×	680 1.2×	361 0.7×	315 0.7×	171 0.4×	84	1.7k
Ying Zhu China	34	1.5k 1.8×	754 1.3×	898 1.7×	897 1.9×	254 0.5×	145	3.4k
Huaxiang Xu China	23	735 0.8×	1.0k 1.8×	662 1.2×	477 1.0×	152 0.3×	54	2.1k
Zhi Yang China	30	1.6k 1.9×	832 1.5×	306 0.6×	891 1.9×	209 0.4×	113	3.0k
Norio Kubo Japan	23	568 0.7×	673 1.2×	219 0.4×	314 0.7×	220 0.5×	143	1.9k
Tina Manon‐Jensen Denmark	21	699 0.8×	260 0.5×	295 0.6×	315 0.7×	242 0.5×	60	2.3k
Jianfei Tu China	24	654 0.8×	273 0.5×	185 0.3×	459 1.0×	346 0.7×	90	1.7k
James O. Park United States	28	909 1.0×	722 1.3×	205 0.4×	270 0.6×	492 1.0×	92	2.6k
Fred Fändrich Germany	30	1.2k 1.4×	574 1.0×	633 1.2×	228 0.5×	261 0.6×	114	2.8k

Countries citing papers authored by Di Lu

Since Specialization

Citations

This map shows the geographic impact of Di Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Lu more than expected).

Fields of papers citing papers by Di Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Lu. The network helps show where Di Lu may publish in the future.

Co-authorship network of co-authors of Di Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Di Lu. A scholar is included among the top collaborators of Di Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Lu. Di Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiang, Ze, Jiarui Li, Jiong Yu, et al.. (2025). Impact of Donor CMV‐Seropostive Grafts on Prognosis of Liver Transplantation for Hepatocellular Carcinoma. Journal of Medical Virology. 97(1). e70150–e70150. 1 indexed citations

Wang, Yuying, et al.. (2025). Predictive factors for axillary pathological complete response to neoadjuvant therapy in elderly breast cancer patients. BMC Cancer. 25(1). 156–156.

Chen, Jinyan, Zhigang Hu, Jianyong Zhuo, et al.. (2025). HBV reactivation and its metabolomic profile after liver transplantation for hepatocellular carcinoma in non-alcoholic steatohepatitis. Chinese Journal of Cancer Research. 37(5). 865–878.

Xiang, Xiaonan, Kai Wang, Hui Zhang, et al.. (2024). Blocking CX3CR1+ Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma. Cancer Immunology Research. 12(11). 1603–1620. 10 indexed citations

Lu, Di, Abid Khan, Qingguo Xu, et al.. (2024). Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. Journal of Cachexia Sarcopenia and Muscle. 15(5). 2071–2083. 6 indexed citations

Lu, Di, et al.. (2024). Microvilli control the morphogenesis of the tectorial membrane extracellular matrix. Developmental Cell. 60(5). 679–695.e8. 3 indexed citations

Wang, Shuai, Lijun Meng, Huan Chen, et al.. (2024). Hepatocellular carcinoma-specific epigenetic checkpoints bidirectionally regulate the antitumor immunity of CD4 + T cells. Cellular and Molecular Immunology. 21(11). 1296–1308. 5 indexed citations

Chen, Jinyan, Jianyong Zhuo, Zuyuan Lin, et al.. (2024). Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma. Cancer Biology and Medicine. 21(11). 1033–1049. 3 indexed citations

Yang, Mengfan, Xiangyu Zhai, Xinyu Yang, et al.. (2024). Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantation. Cellular and Molecular Life Sciences. 81(1). 83–83. 5 indexed citations

10.

Wang, Shuai, Jianguo Wang, Yiyuan Chen, et al.. (2023). BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy. Cancer Letters. 571. 216336–216336. 12 indexed citations

11.

Zhuo, Jianyong, Yiyuan Chen, Huan Chen, et al.. (2023). Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression. British Journal of Cancer. 130(2). 201–212. 7 indexed citations

12.

Wang, Shuai, Rui Wang, Xuyong Wei, et al.. (2023). SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment. Hepatology. 78(4). 1064–1078. 33 indexed citations

13.

Zhang, Junbo, Chengwu Liu, Haikuo Zhang, et al.. (2023). A compact interphase involving a reversible redox couple stabilizes a 4.6 V LiCoO₂ cathode. Journal of Materials Chemistry A. 11(16). 8766–8775. 7 indexed citations

14.

Yang, Fan, Xiaoyong Shen, Yichao Wu, et al.. (2023). Application of multi-modality MRI-based radiomics in the pre-treatment prediction of RPS6K expression in hepatocellular carcinoma. Molecular Biomedicine. 4(1). 22–22. 3 indexed citations

15.

Zhuo, Jianyong, Di Lu, Jianguo Wang, et al.. (2021). Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts. Chinese Journal of Cancer Research. 33(4). 470–479. 10 indexed citations

16.

Zhuo, Jianyong, Di Lu, Zuyuan Lin, et al.. (2020). C C motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells. Hepatobiliary & pancreatic diseases international. 19(5). 440–448. 13 indexed citations

17.

Shen, Xiaoyong, Fan Yang, Pengfei Yang, et al.. (2020). A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study. Frontiers in Oncology. 10. 248–248. 35 indexed citations

18.

Lu, Di, Zhujun Yao, Yu Zhong, et al.. (2019). Polypyrrole-Coated Sodium Manganate Hollow Microspheres as a Superior Cathode for Sodium Ion Batteries. ACS Applied Materials & Interfaces. 11(17). 15630–15637. 72 indexed citations

19.

Ling, Sunbin, Jie Li, Qiaonan Shan, et al.. (2017). USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Molecular Oncology. 11(6). 682–695. 84 indexed citations

20.

Xu, Xiao, Di Lu, & Shusen Zheng. (2015). Response to “Influence on the other patients in the waiting list when expanding the Milan criteria” and “Can Milan criteria be expanded effectively for liver transplantation in patients with HCC?”. 4(6). 492–493. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact